IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer. (Q38347818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

1 reference

Vanesa Rodríguez Fanjul

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Cristobal Belda Iniesta

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

I Ibanez de Caceres

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

M Cortes-Sempere

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

C Moratilla

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R Machado-Pinilla

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

C Manguán-García

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

P Cejas

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

F López-Ríos

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

L Paz-Ares

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

J de CastroCarpeño

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

M Nistal

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R Perona

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

21 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

1681-1690

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Induction of the growth inhibitor IGF-binding protein 3 by p53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Acquired cisplatin resistance in the head-neck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Mechanisms of cancer drug resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

TGF-beta control of cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Identification of novel target genes by an epigenetic reactivation screen of renal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

31 March 2020

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Genomic imbalances associated with acquired resistance to platinum analogues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Promoter hypermethylation profile of ovarian epithelial neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Histone deacetylase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Comparative adverse effect profiles of platinum drugs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Drug-induced DNA hypermethylation: a potential mediator of acquired drug resistance during cancer chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

A genomic approach to identify molecular pathways associated with chemotherapy resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.454

31 March 2020

Identifiers

DOI

10.1038/ONC.2009.454

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20023704%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

15 January 2020

1007739941

0 references

1 reference